A phase lb study of ribociclib in combination with doxorubicin in advanced soft tissue sarcomas (aSTS).

被引：0
|
作者：
Davis, Lara E.
Latour, Emile
Burch, Reid
Park, Byung
Davis, Jessica L.
Ryan, Christopher W.
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11548
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase lb study of decitabine in combination with gemcitabine in treatment of advanced soft tissue and bone sarcomas.
    Monga, Varun
    Dodd, Rebecca
    Scherer, Amanda
    Gutierrez, Wade Robert
    Tanas, Munir
    Mott, Sarah L.
    Milhem, Mohammed M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Paclitaxel in combination with doxorubicin in advanced adult soft tissue sarcoma (ASTS): A Hellenic co-operative phase II study
    Bafaloukos, D
    Skarlos, D
    Fountzilas, G
    Dimopoulos, AM
    Kosmidis, P
    ANNALS OF ONCOLOGY, 1998, 9 : 119 - 119
  • [3] Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy
    Barista, I
    Tekuzman, G
    Yalçin, S
    Güllü, I
    Güler, N
    Özisik, Y
    Kars, A
    Çelik, I
    Türker, A
    Altundag, K
    Zengin, N
    Üner, A
    Baltali, E
    Firat, D
    JOURNAL OF SURGICAL ONCOLOGY, 2000, 73 (01) : 12 - 16
  • [4] Phase Ib study of RG7112 with doxorubicin (D) in advanced soft tissue sarcoma (ASTS).
    Chawla, Sant P.
    Blay, Jean-Yves
    Italiano, Antoine
    Gutierrez, Martin
    Le Cesne, Axel
    Gomez-Roca, Carlos Alberto
    Gouw, Launce G.
    von Mehren, Margaret
    Wagner, Andrew
    Maki, Robert G.
    Higgins, Brian
    Middleton, Steven
    Nichols, Gwen L.
    Geho, David
    Blotner, Steven
    Zhi, Jianguo
    Chen, Lin Chi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Concomitant interleukin-2-doxorubicin (ADR) schedule in patients (PTS) with advanced soft tissue sarcomas (ASTS): A pharmacokinetic study
    LeCesne, A
    Vassal, G
    Farace, F
    Spielmann, M
    LeChevalier, T
    Tursz, T
    Escudier, B
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 586 - 586
  • [6] A phase II study of raltitrexed ('Tomudex') as second or third line treatment for patients (pts) with advanced soft tissue sarcomas (ASTS) refractory to doxorubicin containing regimens
    Blay, JY
    Judson, I
    Rodenhuis, S
    Hermans, C
    Smith, M
    van Glabbeke, M
    Verweij, J
    ANNALS OF ONCOLOGY, 1998, 9 : 118 - 118
  • [7] Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas
    Losa, R.
    Fra, J.
    Lopez-Pousa, A.
    Sierra, M.
    Goitia, A.
    Una, E.
    Nadal, R.
    del Muro, J. Garcia
    Gion, M.
    Maurel, J.
    Escudero, P.
    Esteban, E.
    Buesa, Jose M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (02) : 251 - 259
  • [8] Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas
    R. Losa
    J. Fra
    A. López-Pousa
    M. Sierra
    A. Goitia
    E. Uña
    R. Nadal
    J. García del Muro
    M. Gión
    J. Maurel
    P. Escudero
    E. Esteban
    José M. Buesa
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 251 - 259
  • [9] Phase II Trial of Liposomal Doxorubicin (Doxil®) in Advanced Soft Tissue Sarcomas
    T. Chidiac
    G.T. Budd
    R. Pelley
    K. Sandstrom
    D. McLain
    P. Elson
    R. Crownover
    K. Marks
    G. Muschler
    M. Joyce
    R. Zehr
    R. Bukowski
    Investigational New Drugs, 2000, 18 : 253 - 259
  • [10] Phase II trial of liposomal doxorubicin (Doxil®) in advanced soft tissue sarcomas
    Chidiac, T
    Budd, GT
    Pelley, R
    Sandstrom, K
    McLain, D
    Elson, P
    Crownover, R
    Marks, K
    Muschler, G
    Joyce, M
    Zehr, R
    Bukowski, R
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (03) : 253 - 259
12345